Lixin Zheng

CIO, Investment Committee Member

Mr. Zheng is the founder and chairman of DM Capital, CIO of Harmony Healthcare Fund and Member of the Investment Committee of the Essence DM Dental Fund. Mr. Zheng was the Chairman of the Board and CEO of Longlife Group (08037.hk). He orchestrated a restructuring of the company between 2007 and 2009. Before that Mr. Zheng managed discretionary stock accounts in Hong Kong for family and friends between 2004 and 2007 mainly practicing a Constructive Activist strategy. His investment portfolio reached US $50 million with approximately 500% total return to investors.

 

Mr. Zheng held senior positions in international and domestic Chinese pharmaceutical companies like GlaxoWellcome, SmithKline Beecham (now GSK) and Jiangzhong Pharmaceuticals (600750.sh). He also held investment management positions at private equity firms like Tiantu Capital (Shenzhen).

 

Mr. Zheng was the first consultant McKinsey & Company recruited in Canada and stationed in mainland China. At McKinsey, Mr. Zheng was involved in a dozen cross-border acquisition, entry strategy and organizational efficiency projects in the consumer products, building materials, pharmaceuticals, equipment, and technology sectors.

 

Mr. Zheng holds an MBA degree from Ivey Business School at Western University, Canada. He also received a Master's degree from University of Toronto, Canada.